ARMS2 and age-related macular degeneration: However, Clusters 1 and 3 would represent a higher opportunity target sub-population of AMD patients, as they in total represent 50.2% of the neovascular AMD population, and tend to have high blood pressure in combination with a high likelihood of carrying the ARMS2/HTRA1 TT genotype.